Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Cefuroxime × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Interventions

Zoledronic Acid 11 enzalutamide 10 Leuprolide 8 bicalutamide 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Prednisone 6 Nivolumab 6 luprolide acetate gel depot 5 Triptorelin Pamoate 5 Sunitinib 5 Magnetic Resonance Spectroscopy 5 Goserelin 5 Everolimus 5 Abiraterone Acetate 5 Sodium Chloride 4 Propofol 4 Dutasteride 4 Androgen Antagonists 4 pazopanib 3 darolutamide 3 cabazitaxel 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Specimen Handling 3 Prednisolone 3 Midazolam 3 Flutamide 3 Fentanyl 3 Ciprofloxacin 3 5-aminolevulinic acid hexyl ester 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06709196 2025-01-09

REINFORCE

Rigshospitalet, Denmark

Phase 4 Recruiting

Cystectomy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡